Wealth Enhancement Advisory Services LLC Has $3.64 Million Stake in Henry Schein, Inc. (NASDAQ:HSIC)

Wealth Enhancement Advisory Services LLC boosted its position in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 0.5% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 53,134 shares of the company’s stock after acquiring an additional 243 shares during the period. Wealth Enhancement Advisory Services LLC’s holdings in Henry Schein were worth $3,639,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Investment Management Corp VA ADV acquired a new position in Henry Schein during the 4th quarter worth $32,000. Smartleaf Asset Management LLC increased its holdings in shares of Henry Schein by 23.2% during the 4th quarter. Smartleaf Asset Management LLC now owns 759 shares of the company’s stock worth $52,000 after purchasing an additional 143 shares during the period. UMB Bank n.a. increased its holdings in shares of Henry Schein by 23.2% during the 1st quarter. UMB Bank n.a. now owns 1,066 shares of the company’s stock worth $73,000 after purchasing an additional 201 shares during the period. Menard Financial Group LLC bought a new position in shares of Henry Schein during the 4th quarter worth about $92,000. Finally, Canada Post Corp Registered Pension Plan bought a new position in shares of Henry Schein during the 4th quarter worth about $95,000. Institutional investors and hedge funds own 96.62% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts have recently issued reports on the stock. Piper Sandler dropped their price objective on shares of Henry Schein from $83.00 to $77.00 and set an “overweight” rating on the stock in a report on Wednesday, April 30th. Barrington Research dropped their price objective on shares of Henry Schein from $90.00 to $86.00 and set an “outperform” rating on the stock in a report on Tuesday, May 6th. Wells Fargo & Company dropped their price objective on shares of Henry Schein from $80.00 to $75.00 and set an “equal weight” rating on the stock in a report on Tuesday, May 6th. Finally, Wall Street Zen downgraded shares of Henry Schein from a “buy” rating to a “hold” rating in a report on Thursday, April 17th. Six investment analysts have rated the stock with a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $79.30.

Henry Schein Price Performance

NASDAQ:HSIC opened at $73.15 on Friday. The firm has a market cap of $8.90 billion, a PE ratio of 22.86, a price-to-earnings-growth ratio of 2.35 and a beta of 0.86. Henry Schein, Inc. has a 12 month low of $60.56 and a 12 month high of $82.49. The company has a quick ratio of 0.75, a current ratio of 1.38 and a debt-to-equity ratio of 0.50. The company’s 50-day moving average price is $69.59 and its two-hundred day moving average price is $71.24.

Henry Schein (NASDAQ:HSIC) last released its quarterly earnings results on Monday, May 5th. The company reported $1.15 EPS for the quarter, beating analysts’ consensus estimates of $1.11 by $0.04. The firm had revenue of $3.17 billion for the quarter, compared to analyst estimates of $3.24 billion. Henry Schein had a net margin of 3.21% and a return on equity of 14.87%. The company’s revenue for the quarter was down .1% compared to the same quarter last year. During the same period in the previous year, the business earned $1.10 earnings per share. On average, equities analysts anticipate that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.